Agonistic anti-CD40 antibody profoundly suppresses the immune response to infection with lymphocytic choriomeningitis virus

Journal of Immunology

Volumn 178, Issue 3, 2007, Pages 1662-1670

  Bartholdy, Christina ^a   Kauffmann, Susanne Ørding ^a   Christensen, Jan Pravsgaard ^a   Thomsen, Allan Randrup ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD40 ANTIBODY; FAS ANTIGEN; FGK 45; INTERLEUKIN 12; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; UNCLASSIFIED DRUG;

ADOLESCENT; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; HERPES VIRUS; IMMUNE RESPONSE; IMMUNOSURVEILLANCE; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; VESICULAR STOMATITIS VIRUS; VIRUS INFECTION;

EID: 33846498110     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.3.1662     Document Type: Article

References (60)

1. Schoenberger, S. P., R. E. Toes, E. I. van der Voort, R. Offringa, and C. J. Melief. 1998. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393: 480-483.
2. Bennett, S. R., F. R. Carbone, F. Karamalis, R. A. Flavell, J. F. Miller, and W. R. Heath. 1998. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 393: 478-480.
3. + T-helper and a T-killer cell. Nature.393: 474-478.
4. Thomsen, A. R., J. Johansen, O. Marker, and J. P. Christensen. 1996. Exhaustion of CTL memory and recrudescence of viremia in lymphocytic choriomeningitis virus-infected MHC class II-deficient mice and B cell-deficient mice. J. Immunol. 157: 3074-3080.
5. + T cells in cell-mediated immunity to LCMV: studies in MHC class I and class II deficient mice. Scand. J. Immunol. 40: 373-382.
6. + T lymphocytes. Nature 421: 852-856.
7. Shedlock, D. J., and H. Shen. 2003. Requirement for CD4 T-cell help in generating functional CD8 T-cell memory. Science 300: 337-339.
8. Sun, J. C., and M. J. Bevan. 2003. Defective CD8 T-cell memory following acute infection without CD4 T-cell help. Science 300: 339-342.
9. + T cells after acute infection. Nat. Immunol. 5: 927-933.
10. + cytotoxic T-cell responses during chronic viral infection. J. Virol. 68: 8056-8063.
11. von Herrath, M. G., M. Yokoyama, J. Dockter, M. B. Oldstone, and J. L. Whitton. 1996. CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge. J. Virol. 70: 1072-1079.
12. ++ CTL response. J. Exp. Med. 183: 2129-2142.
13. + effector T-cell responses. J. Immunol. 164: 3689-3697.
14. Rolph, M. S., and S. H. Kaufmann. 2001. CD40 signaling converts a minimally immunogenic antigen into a potent vaccine against the intracellular pathogen Listeria monocytogenes. J. Immunol. 166: 5115-5121.
15. Demangel, C., U. Palendira, C. G. Feng, A. W. Heath, A. G. Bean, and W. J. Britton. 2001. Stimulation of dendritic cells via CD40 enhances immune responses to Mycobacterium tuberculosis infection. Infect. Immun. 69: 2456-2461.
16. Ferlin, W. G., W. T. von der, F. Cottrez, D. A. Ferrick, R. L. Coffman, and M. C. Howard. 1998. The induction of a protective response in Leishmania major-infected BALB/c mice with anti-CD40 mAb. Eur. J. Immunol. 28: 525-531.
17. + T-cell effector function in SV40 T antigen transgenic mice. J. Immunol. 171: 697-707.
18. + cell responses. J. Immunol. 170: 2727-2733.
19. + T cells in the absence of tumor-antigen vaccination. Proc. Natl. Acad. Sci. USA 98: 10811-10816.
20. + T cells. J. Immunol. 174: 710-717.
21. den Boer, A. T., L. Diehl, G. J. van Mierlo, E. I. van der Voort, M. F. Fransen, P. Krimpenfort, C. J. Melief, R. Offringa, and R. E. Toes. 2001. Longevity of antigen presentation and activation status of APC are decisive factors in the balance between CTL immunity versus tolerance. J. Immunol. 167: 2522-2528.
22. -/- dendritic cells to provide tumor protection is rescued by CD40 ligation. J. Immunol. 163: 77-81.
23. Lefrancois, L., J. D. Altman, K. Williams, and S. Olson. 2000. Soluble antigen and CD40 triggering are sufficient to induce primary and memory cytotoxic T cells. J. Immunol. 164: 725-732.
24. Maxwell, J. R., J. D. Campbell, C. H. Kim, and A. T. Vella. 1999. CD40 activation boosts T-cell immunity in vivo by enhancing T-cell clonal expansion and delaying peripheral T cell deletion. J. Immunol. 162: 2024-2034.
25. Storni, T., F. Lechner, I. Erdmann, T. Bachi, A. Jegerlehner, T. Dumrese, T. M. Kundig, C. Ruedl, and M. F. Bachmann. 2002. Critical role for activation of antigen-presenting cells in priming of cytotoxic T cell responses after vaccination with virus-like particles. J. Immunol. 168: 2880-2886.
26. Ichikawa, H. T., L. P. Williams, and B. M. Segal. 2002. Activation of APCs through CD40 or Toll-like receptor 9 overcomes tolerance and precipitates autoimmune disease. J. Immunol. 169: 2781-2787.
27. + T cells requires CD154 expression by Th cells in acute graft-versus-host disease. J. Immunol. 162: 4373-4376.
28. Roth, E., J. Schwartzkopff, and H. Pitcher. 2002. CD40 ligation in the presence of self-reactive CD8 T cells leads to severe immunopathology. J. Immunol. 168: 5124-5129.
29. Kimura, K., H. Moriwaki, M. Nagaki, M. Saio, Y. Nakamoto, M. Naito, K. Kuwata, and F. V. Chisari. 2006. Pathogenic role of B cells in anti-CD40-induced necroinflammatory liver disease. Am. J. Pathol. 168: 786-795.
30. Wiley, J. A., R. Geha, and A. G. Harmsen. 1997. Exogenous CD40 ligand induces a pulmonary inflammation response. J. Immunol. 158: 2932-2938.
31. Sarawar, S. R., B. J. Lee, S. K. Reiter, and S. P. Schoenberger. 2001. Stimulation via CD40 can substitute for CD4 T-cell function in preventing reactivation of a latent herpesvirus. Proc. Natl. Acad. Sci. USA 98: 6325-6329.
32. Kimura, K., K. Kakimi, S. Wieland, L. G. Guidotti, and F. V. Chisari. 2002. Activated intrahepatic antigen-presenting cells inhibit hepatitis B virus replication in the liver of transgenic mice. J. Immunol. 169: 5188-5195.
33. + T lymphocytes mediate clearance of virus and regulate the antiviral antibody response. J. Virol. 61: 1867-1874.
34. Moskophidis, D., F. Lechner, H. Pircher, and R. M. Zinkernagel. 1993. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 362: 758-761.
35. Marker, O., and M. Volkert. 1973. Studies on cell-mediated immunity to lymphocytic choriomeningitis virus in mice. J. Exp. Med. 137: 1511-1525.
36. Thomsen, A. R., A. Nansen, J. P. Christensen, S. O. Andreasen, and O. Marker. 1998. CD40 ligand is pivotal, to efficient control of virus replication in mice infected with lymphocytic choriomeningitis virus. J. Immunol. 161: 4583-4590.
37. Zajac, A. J., J. N. Blattman, K. Murali-Krishna, D. J. Sourdive, M. Suresh, J. D. Altman, and R. Ahmed. 1998. Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 188: 2205-2213.
38. Yanagi, Y., A. Tishon, H. Lewicki, B. A. Cubitt, and M. B. Oldstone. 1992. Diversity of T-cell receptors in virus-specific cytotoxic T lymphocytes recognizing three distinct viral epitopes restricted by a single major histocompatibility complex molecule. J. Virol. 66: 2527-2531.
39. Ahmed, R., and M. B. Oldstone. 1988. Organ-specific selection of viral variants during chronic infection. J. Exp. Med. 167: 1719-1724.
40. + T cells during viral infection: correlation with stable memory development. J. Gen. Virol. 83: 2123-2133.
41. Baer, G. M., and W. F. Cleary. 1972. A model in mice for the pathogenesis and treatment of rabies. J. Infect. Dis. 125: 520-527.
42. Zinkernagel, R. M., A. Althage, and J. Holland. 1978. Target antigens for H-2-restricted vesicular stomatitis virus-specific cytotoxic T cells. J. Immunol. 121: 744-748.
43. Battegay, M., S. Cooper, A. Althage, J. Banziger, H. Hengartner, and R. M. Zinkernagel. 1991. Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates. J. Virol. Methods 33: 191-198.
44. Rolink, A., F. Melchers, and J. Andersson. 1996. The SCID but not the RAG-2 gene product is required for Sμ-Sε heavy chain class switching. Immunity 5: 319-330.
45. Thompson, L. J., G. A. Kolumam, S. Thomas, and K. Murali-Krishna. 2006. Innate inflammatory signals induced by various pathogens differentially dictate the IFN-I dependence of CD8 T cells for clonal expansion and memory formation. J. Immunol. 177: 1746-1754.
46. Thomsen, A. R., A. Nansen, C. Andersen, J. Johansen, O. Marker, and J. P. Christensen. 1997. Cooperation of B cells and T cells is required for survival of mice infected with vesicular stomatitis virus. Int. Immunol. 9: 1757-1766.
47. + T cell-mediated protection against a lethal outcome of systemic infection with vesicular stomatitis virus requires CD40 ligand expression, but not IFN-γ or IL-4. Int. Immunol. 11: 2035-2042.
48. Filatenkov, A. A., E. L. Jacovetty, U. B. Fischer, J. M. Curtsinger, M. F. Mescher, and E. Ingulli. 2005. CD4 T cell-dependent conditioning of dendritic cells to produce IL-12 results in CD8-mediated graft rejection and avoidance of tolerance. J. Immunol. 174: 6909-6917.
49. Orange, J. S., S. F. Wolf, and C. A. Biron. 1994. Effects of IL-12 on the response and susceptibility to experimental viral infections. J. Immunol. 152: 1253-1264.
50. Orange, J. S., T. P. Salazar-Mather, S. M. Opal, R. L. Spencer, A. H. Miller, B. S. McEwen, and C. A. Biron. 1995. Mechanism of interleukin 12-mediated toxicities during experimental viral infections: role of tumor necrosis factor and glucocorticoids. J. Exp. Med. 181: 901-914.
51. Green, D. R., N. Droin, and M. Pinkoski. 2003. Activation-induced cell death in T cells. Immunol. Rev. 193: 70-81.
52. Toes, R. E., S. P. Schoenberger, E. I. van der Voort, R. Offringa, and C. J. Melief. 1998. CD40-CD40 ligand interactions and their role in cytotoxic T lymphocyte priming and anti-tumor immunity. Semin. Immunol. 10: 443-448.
53. + T cells mediate CD40-independent maturation of dendritic cells in vivo. J. Exp. Med. 189: 1875-1884.
54. + T cells varies with activation state and localization, but not with TCR avidity. J. Gen. Virol. 85: 1703-1712.
55. + T cells responding to self-antigens. J. Exp. Med. 196: 323-333.
56. Zhou, S., R. Ou, L. Huang, and D. Moskophidis. 2002. Critical role for perform-, Fas/FasL-, and TNFR1-mediated cytotoxic pathways in down-regulation of antigen-specific T cells during persistent viral infection. J. Virol. 76: 829-840.
57. Seville, N., D. B. McGavern, C. Teng, S. Kunz, and M. B. Oldstone. 2004. Viral targeting of hematopoietic progenitors and inhibition of DC maturation as a dual strategy for immune subversion. J. Clin. Invest. 113: 737-745.
58. Seville, N., S. Kunz, A. Holz, H. Lewicki, D. Homann, H. Yamada, K. P. Campbell, J. C. de La Torre, and M. B. Oldstone. 2000. Immunosuppression and resultant viral persistence by specific viral targeting of dendritic cells. J. Exp. Med. 192: 1249-1260.
59. Matsui, K., S. Jodo, S. Xiao, and S. T. Ju. 1999. Hypothesis: a recurrent, moderate activation fosters systemic autoimmunity: the apoptotic roles of TCR, IL-2 and Fas ligand. J. Biomed. Sci. 6: 306-313.
60. de Goer de Herve, M. G., D. Durali, T. A. Tran, G. Maigne, F. Simonetta, P. Leclerc, J. F. Delfraissy, and Y. Taoufik. 2005. Differential effect of agonistic anti-CD40 on human mature and immature dendritic cells: the Janus face of anti-CD40. Blood 106: 2806-2814.